$HZNP Recent News Why this year’s rally is not the

New Post Public Reply Private Reply Replies (0) Message Board

Aug 16, 2014 at 12:37 PM

$HZNP Recent News

Why this year’s rally is not the same as last year’s 2:27 p.m. July 15, 2014 - The Trading Deck
Stocks are poised for a jump higher 12:30 p.m. June 10, 2014 - The Trading Deck
Two health-care names ready to run 12:28 p.m. June 5, 2014 - The Trading Deck
6 stocks to watch 3:13 p.m. June 4, 2014 - The Trading Deck
Charting a bullish second-quarter backdrop 12:34 p.m. April 1, 2014 - Michael Ashbaugh
Charting a bullish second-quarter backdrop 12:20 p.m. April 1, 2014 - Michael Ashbaugh
S&P 500 retests major support 12:47 p.m. March 27, 2014 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com

Horizon Pharma: Upbeat 2015 Guidance Increases Confidence 8:35 a.m. Aug. 11, 2014 - Seeking Alpha
Horizon Pharma Offers Update on Effectiveness of S-4 Registration 6:32 a.m. Aug. 8, 2014 - benzinga.com
Horizon Pharma's (HZNP) CEO Tim Walbert on Q2 2014 Results - Earnings Call Transcript 2:09 p.m. Aug. 7, 2014 - Seeking Alpha
Horizon Pharma (HZNP) Q2 2014 Results - Earnings Call Webcast 7:55 a.m. Aug. 7, 2014 - Seeking Alpha
10-Q: HORIZON PHARMA, INC. 6:53 a.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings before Thursday’s open 5:30 p.m. Aug. 6, 2014 - Seeking Alpha
Will Horizon Pharma (HZNP) Earnings Miss Estimates in Q2? - Analyst Blog 5:00 p.m. Aug. 6, 2014 - Zacks.com
Great Buying Opportunity In Pozen Shares 10:11 a.m. July 30, 2014 - Seeking Alpha
Why Horizon Pharmaceuticals (HZNP) Is Plummeting Today 2:25 p.m. July 28, 2014 - TheStreet.com
Horizon Pharma Shares Fall as Drugs Added to Exclusion List 12:33 p.m. July 28, 2014 - The Wall Street Journal Interactive Edition
Access to Horizon Pharma Drugs Cut By Two Leading PBMs 10:56 a.m. July 28, 2014 - TheStreet.com
Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls 10:14 a.m. July 28, 2014 - Investors Business Daily
Update: Horizon Pharma's Duexis And Vimovo To Be Taken Off Formularies By Express Scripts And CVS Caremark In 2015 9:18 a.m. July 28, 2014 - Seeking Alpha
Two PBMs drop Horizon NSAIDs 9:03 a.m. July 28, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – HZNP ARNA GB SGEN 2:15 p.m. July 10, 2014 - InvestorPlace.com
5 Newly Profitable Stocks to Buy – Screen of the Week 6:59 a.m. July 9, 2014 - InvestorPlace.com
A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week 2:11 a.m. July 8, 2014 - Zacks.com
Salix Pharmaceuticals Surges on Positive IBS Data - Analyst Blog 6:15 p.m. July 2, 2014 - Zacks.com
Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog 5:55 p.m. July 2, 2014 - Zacks.com
Hottest Healthcare Stocks Now – IRWD IPXL EXAM HZNP 2:00 p.m. June 19, 2014 - InvestorPlace.com

Horizon Pharma Announces U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen / esomeprazole) Delayed Release Tablets 7:31 a.m. Aug. 13, 2014 - Marketwire
Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver 9:31 a.m. Aug. 8, 2014 - PR Newswire - PRF
Horizon Pharma Announces Effectiveness of S-4 Registration Statement for Acquisition of Vidara Therapeutics International Public Company Limited 7:31 a.m. Aug. 8, 2014 - Marketwire
Horizon Pharma Reports Second Quarter 2014 Financial Results and Provides Business Update 6:31 a.m. Aug. 7, 2014 - Marketwire
Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma 9:10 a.m. Aug. 6, 2014 - PR Newswire - PRF
Horizon Pharma Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering VIMOVO(R) (Naproxen / Esomeprazole) Delayed Release Tablets 7:31 a.m. Aug. 5, 2014 - Marketwire
Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis 9:20 a.m. July 31, 2014 - PR Newswire - PRF
Horizon Pharma to Host Conference Call and Webcast to Discuss Second Quarter 2014 Financial Results on August 7, 2014 7:30 a.m. July 29, 2014 - Marketwire
Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 6:50 a.m. July 2, 2014 - PR Newswire - PRF
Market Expansion, Merger Agreements, Management Transitions, and Market Activity - Analyst Notes on Intuitive Surgical, Auxilium, Horizon Pharma, Tesaro and ArQule 6:30 a.m. July 2, 2014 - PR Newswire - PRF
Horizon Pharma Announces Execution of $300 Million Senior Secured Credit Agreement in Connection With the Proposed Acquisition of Vidara 7:01 a.m. June 19, 2014 - Marketwire
Horizon Pharma Announces Robert J. De Vaere to Retire and Names Paul W. Hoelscher Chief Financial Officer 7:01 a.m. June 18, 2014 - Marketwire
Horizon Pharma to Present at the JMP Securities Healthcare Conference 2014 3:25 p.m. June 17, 2014 - Marketwire
Consent Expiry Extensions, Collaborations, Grants, Conference Presentations, and FDA Approvals - Analyst Notes on Forest Laboratories, Intuitive Surgical, Horizon Pharma, Cubist and BDSI 6:10 a.m. June 12, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:45 p.m. June 6, 2014 - Marketwire
Top Gainers Roundup -- Research on Horizon Pharma, Celldex Therapeutics, Extreme Networks, and WidePoint 6:17 a.m. May 28, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 27, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:11 p.m. May 23, 2014 - Marketwire
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Horizon Pharma Reports First Quarter 2014 Financial Results Exceeding Expectations and Raises 2014 Full-Year Guidance 6:31 a.m. May 9, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MINISO Prepares to Reveal September 2026 Results

News flash, folks — MINISO Group, that quirky IP-driven retailer we all have an eye on, has set the stage for its next big reveal. Come November 17, 2026, they’re gonna lay down their financial cards for the September quarter. It’s prime time for any investor keen on dissecting their performance and plans for the future. What the Call Means for Stakeholders MINISO's...

Jon Gregoire Leads Parkview's Next Growth Phase

Steering Parkview into New Waters Every now and then, a company gets a leader who feels like a tailor-made fit for its ambitions. Parkview Dental Partners just scored big with Jon Gregoire taking the helm as CEO. Gregoire, a seasoned DSO bigwig with a knack for M&A, is set to power up the gears for Parkview’s next growth spurt. We're talking about a guy who knows the...

Farmer Sentiment Rises, Hints of Cautious Optimism

Sifting Through October's Optimism: Farmers' Sentiments October saw a glimmer of hope in the agricultural sector as the Purdue University/CME Group Ag Economy Barometer inched upward from 123 to 126. Sure, it's not a fireworks display, but it's a far cry from doom and gloom. This slim gain in sentiment comes on the coattails of some government help through Agriculture...

Vanessa Hering's Empathetic Model Wins 2026 Herizon Award

Recognizing a Game-Changer in Financial Wellness Vanessa Hering's name isn't just getting thrown around for no reason, folks. She's the client success officer at Beyond Finance, a heavyweight in the financial wellness arena, and she's just snagged the 2026 Herizon Award. This ain't some run-of-the-mill accolade; it acknowledges the profound changes she's spearheaded in...

Toufayan's Sourdough Pita: A Century-Old Recipe Revival

Crafting Tradition in Modern Times Ever see a family business stick to its roots despite the whirlwind of fleeting trends? Step aside, because Toufayan isn’t just baking bread—they're pulling a Houdini act, bringing a recipe out of the past and into our grocery aisles. By launching their Simply Sourdough pita, these folks are banking on good ol’ nostalgia and...

Bakery China's International Buyer Surge: A 50% Boost

Look Who's Lining Up for Chinese Pastries Alright, here we go. China's baking scene is pulling in audiences far and wide, as if the whole world suddenly caught a whiff of their freshest, steaming buns. The 11th Bakery China Autumn, recently wrapped up at the Wuhan International Expo Center, saw a 50% rise in international buyers. This stat gives you that warm and cozy...

StackRails Unleashes AI Power with Contextual Clarity

AI's Blind Spots Exposed Let's get this straight—plugging AI into enterprise coding projects without context is like sending a blindfolded sprinter onto a city's marathon route. Sure, they'll move, but who knows what havoc they'll wreak along the way? That's where StackRails steps up to the plate, aiming to dispel the chaos with a robust grip on the bigger picture. The...

WareSpace Expands in U.S. with Key Site Acquisitions

WareSpace's National Growth Strategy: A New Expansion Chapter They say everything's bigger in Texas, but WareSpace is showing that smaller can be mighty impactful too. With its shrewd acquisition of sites in Houston's Inner Loop and Fremont's Warm Springs corridor, WareSpace is playing it smart, appeasing that roaring demand for tiny but mighty warehouse spaces across...

Elanco Heads to UBS Global Healthcare—What Matters

Elanco's Strategy Under the Spotlight at UBS Confab Right off the bat, let's chew over why Elanco’s trip to the UBS Global Healthcare Conference ain’t just another checkbox on a corporate to-do list. It’s where the nitty-gritty of their strategy reveals itself, as Bob VanHimbergen and Bobby Modi step into the spotlight on November 9. While not everyone's shouting...

Mace Consult Ushers in New CFO for Growth Phase

Shaun Hughes Steps into Mace Consult's Financial Helm When a company like Mace Consult brings in someone with Shaun Hughes' pedigree as CFO, you know they're preparing for something big. This isn't exactly a cat nap in the park. With over two decades of driving financial strategy and performance across continents, Hughes isn't stepping into this role to twiddle his...